Genomic Abnormalities as Biomarkers and Therapeutic Targets in Acute Myeloid Leukemia

por Ribeiro, Sara, Eiring, Anna M., Khorashad, Jamshid S.
Publicado 2021

New concepts for CML clonality

por Khorashad, Jamshid S., Deininger, Michael W., O'Hare, Thomas
Publicado 2013

Advances in the treatment of chronic myeloid leukemia

por Eiring, Anna M, Khorashad, Jamshid S, Morley, Kimberly, Deininger, Michael W
Publicado 2011

Coexistence of two missense mutations in the KRAS gene in adenocarcinoma of the lung: a possible indicator of poor prognosis

por Spinelli, Manuela, Du Parcq, Persephone, Gupta, Nandita, Khorashad, Jamshid, Viola, Patrizia
Publicado 2022

A Role for the Bone Marrow Microenvironment in Drug Resistance of Acute Myeloid Leukemia

por Bolandi, Seyed Mohammadreza, Pakjoo, Mahdi, Beigi, Peyman, Kiani, Mohammad, Allahgholipour, Ali, Goudarzi, Negar, Khorashad, Jamshid S., Eiring, Anna M.
Publicado 2021

FISH-negative BCR::ABL1-positive e19a2 chronic myeloid leukaemia: the most cryptic of insertions

por May, Philippa C., Reid, Alistair G., Robinson, Mark E., Khorashad, Jamshid S., Milojkovic, Dragana, Claudiani, Simone, Willis, Fenella, Apperley, Jane F., Innes, Andrew J.
Publicado 2023

Ongoing Clonal Evolution in Chronic Myelomonocytic Leukemia on Hypomethylating Agents: A Computational Perspective

por Than, Hein, Qiao, Yi, Huang, Xiaomeng, Yan, Dongqing, Khorashad, Jamshid S., Pomicter, Anthony D., Kovacsovics, Tibor J., Marth, Gabor T., O’Hare, Thomas, Deininger, Michael W.
Publicado 2018

MR4 sustained for 12 months is associated with stable deep molecular responses in chronic myeloid leukemia

por Claudiani, Simone, Gatenby, Aoife, Szydlo, Richard, Nesr, George, Abulafia, Adi Shacham, Palanicawandar, Renuka, Nteliopoulos, Georgios, Khorashad, Jamshid, Foroni, Letizia, Apperley, Jane F., Milojkovic, Dragana
Publicado 2019

Somatic variants in epigenetic modifiers can predict failure of response to imatinib but not to second-generation tyrosine kinase inhibitors

por Nteliopoulos, Georgios, Bazeos, Alexandra, Claudiani, Simone, Gerrard, Gareth, Curry, Edward, Szydlo, Richard, Alikian, Mary, Foong, Hui En, Nikolakopoulou, Zacharoula, Loaiza, Sandra, Khorashad, Jamshid S., Milojkovic, Dragana, Perrotti, Danilo, Gale, Robert Peter, Foroni, Letizia, Apperley, Jane F.
Publicado 2019

RAPID CONVERSION OF CHRONIC MYELOID LEUKEMIA TO CHRONIC MYELOMONOCYTIC LEUKEMIA IN A PATIENT ON IMATINIB THERAPY

por Khorashad, Jamshid S., Tantravahi, Srinivas K., Yan, Dongqing, Mason, Clinton C., Qiao, Yi, Eiring, Anna M., Gligorich, Keith, Hein, Than, Pomicter, Anthony D., Reid, Alistair G., Kelley, Todd W., Marth, Gabor T., O'Hare, Thomas, Deininger, Michael W.
Publicado 2016

Carfilzomib Enhances the Suppressive Effect of Ruxolitinib in Myelofibrosis

por Claudiani, Simone, Mason, Clinton C., Milojkovic, Dragana, Bianchi, Andrea, Pellegrini, Cristina, Di Marco, Antinisca, Fiol, Carme R., Robinson, Mark, Ponnusamy, Kanagaraju, Mokretar, Katya, Chowdhury, Avirup, Albert, Michael, Reid, Alistair G., Deininger, Michael W., Naresh, Kikkeri, Apperley, Jane F., Khorashad, Jamshid S.
Publicado 2021

β-Catenin is required for intrinsic but not extrinsic BCR-ABL1 kinase-independent resistance to tyrosine kinase inhibitors in chronic myeloid leukemia

por Eiring, Anna M., Khorashad, Jamshid S., Anderson, David J., Yu, Fan, Redwine, Hannah M., Mason, Clinton C., Reynolds, Kimberly R., Clair, Phillip M., Gantz, Kevin C., Zhang, Tian Y., Pomicter, Anthony D., Kraft, Ira L., Bowler, Amber D., Johnson, Kara, Mac Partlin, Mary, O’Hare, Thomas, Deininger, Michael W.
Publicado 2015

Proteasome 26S subunit, non-ATPases 1 (PSMD1) and 3 (PSMD3), play an oncogenic role in chronic myeloid leukemia by stabilizing nuclear factor-kappa B

por Bencomo-Alvarez, Alfonso E., Rubio, Andres J., Olivas, Idaly M., Gonzalez, Mayra A., Ellwood, Rebecca, Fiol, Carme Ripoll, Eide, Christopher A., Lara, Joshua J., Barreto-Vargas, Christian, Jave-Suarez, Luis F., Nteliopoulos, Georgios, Reid, Alistair G., Milojkovic, Dragana, Druker, Brian J., Apperley, Jane, Khorashad, Jamshid S., Eiring, Anna M.
Publicado 2021

Combined STAT3 and BCR-ABL1 Inhibition Induces Synthetic Lethality in Therapy-Resistant Chronic Myeloid Leukemia

por Eiring, Anna M., Page, Brent D. G., Kraft, Ira L., Mason, Clinton C., Vellore, Nadeem A., Resetca, Diana, Zabriskie, Matthew S., Zhang, Tian Y., Khorashad, Jamshid S., Engar, Alexander J., Reynolds, Kimberly R., Anderson, David J., Senina, Anna, Pomicter, Anthony D., Arpin, Carolynn C., Ahmad, Shazia, Heaton, William L., Tantravahi, Srinivas K., Todic, Aleksandra, Moriggl, Richard, Wilson, Derek J., Baron, Riccardo, O'Hare, Thomas, Gunning, Patrick T., Deininger, Michael W.
Publicado 2014